C J Gerrits
About
In The Last Decade
C J Gerrits
12 papers receiving 323 citations
Peers
Comparison fields: 5 of 45
- Oncology 259
- Molecular Biology 216
- Epidemiology 63
- Neurology 49
- Surgery 43
Countries citing papers authored by C J Gerrits
This map shows the geographic impact of C J Gerrits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C J Gerrits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C J Gerrits more than expected).
Fields of papers citing papers by C J Gerrits
This network shows the impact of papers produced by C J Gerrits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C J Gerrits. The network helps show where C J Gerrits may publish in the future.
Co-authorship network of co-authors of C J Gerrits
This figure shows the co-authorship network connecting the top 25 collaborators of C J Gerrits. A scholar is included among the top collaborators of C J Gerrits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C J Gerrits. C J Gerrits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 29 | |
| 4 | A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin) | 53 |
| 5 | Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors. | 34 |
| 6 | 56 | |
| 7 | 66 | |
| 8 | 5 | |
| 9 | 15 | |
| 10 | 56 | |
| 11 | 4 | |
| 12 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.